Background {#Sec1}
==========

Worldwide, osteoarthritis (OA) is the most prevalent joint disease and strongly associated with aging and obesity. The knee is the joint most commonly affected by OA with an estimated prevalence of 15% in persons aged 56 to 84 years \[[@CR1]\].

The most important risk factors for knee OA include obesity, previous knee injury, and family history of OA \[[@CR2]\]. The impact of each factor is debated but obesity is believed to be the most important. Thus, a recent systematic review found that onset of OA knee pain in persons over 50 years of age was related to overweight or obesity in 25% of cases; only 5% were caused by previous knee injury \[[@CR3]\].

The end stage of OA is characterized by severe pain, disability and joint deformity and total knee arthroplasty (TKA) is often the only effective treatment. A recent study by Weinstein et al. \[[@CR4]\] estimated that approximately 52% of adults diagnosed with symptomatic knee OA in the US will undergo TKA. Thus, approximately half of the population with knee OA will not progress to end stage disease and TKA. This has led some to suggest that other factors may be involved in disease manifestation than in disease progression \[[@CR2], [@CR5]\].

Conventional radiography is the most commonly used modality for imaging of knee OA although the radiographic changes in knee OA are generally not well correlated with symptoms \[[@CR6]\]. However, the radiographic features of OA have been shown to correlate with disease progression and TKA \[[@CR7], [@CR8]\], especially the degree of joint space narrowing (JSN) \[[@CR9]\]. Magnetic resonance imaging (MRI) offers the ability to visualize all structures in and around the knee, including cartilage, subchondral bone and soft tissue. Specific pathologic findings on MRI, including bone marrow lesions (BMLs) and synovitis, are moderately correlated with pain and have been associated with risk of TKA in studies with short term follow-up \[[@CR9]--[@CR12]\] as well as with progression of JSN \[[@CR13], [@CR14]\].

The purpose of our study was to analyze whether clinical, radiographic and MRI findings, including BML and synovitis, correlate with the incidence of TKA during a mean follow-up period of 15 years.

Methods {#Sec2}
=======

Data sources {#Sec3}
------------

The study was partly based on data from the following Danish registers:

The Danish Civil Registration System, established in 1968, assigns a 10-digit personal identification number to all Danish citizens at birth or immigration. This unique civil registration number can be used across all Danish registers and provide highly reliable data at individual level.

The Danish National Patient Register, established in 1977, includes data on all hospital in-patient contacts. Since 1995, data on out-patient contacts has also been included. Both public and private hospitals are obliged to report discharge diagnoses to the register, which are coded according to the Danish version of the International Classification of Diseases (ICD-10).

Participants {#Sec4}
------------

Participants were selected from a previous multi-center, randomized, placebo-controlled double-blind trial including 337 participants comparing five intra-articular injections of Hyalgan® and placebo, respectively \[[@CR15]\]. All included participants fulfilled the American College of Rheumatology (ACR) criteria for primary OA \[[@CR16]\], had a Lequesne Algofunctional Index score of 10 or more (maximum score 24), a normal C-reactive protein level and e-GFR ≥ 60. The participants entered the study between January 2000 and December 2002. Exclusion criteria were secondary OA, inflammatory joint disease, significant OA symptoms from the other knee, radiographic OA in more than one tibiofemoral compartment, radiographic attrition \>5 mm or severe co-morbidity (e.g. cancer and poor general health). One hundred and two participants were enrolled at our institution, constituting the potential study population for the present study.

Baseline radiographs were missing in two, leaving 100 participants with baseline radiographs and clinical data (Fig. [1](#Fig1){ref-type="fig"}). MRI was missing in seven participants with tibiofemoral OA, and 10 participants with only patellofemoral OA were excluded from the analyses of MR findings because the MRI protocol did not include an axial STIR sequence; thus, the MRI analyses were confined to 83 participants (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Diagram showing participant flow. MRI: magnetic resonance imaging; OA: osteoarthritis

The original study was approved by the Central Denmark Region Committee on Health Research Ethics and was carried out in accordance with the Declaration of Helsinki. Participants gave written informed consent prior to participation, including consent to publish study results and images. Prior to our follow-up study we contacted The Central Denmark Region Committees on Health Research Ethics who waived the need for ethical approval as no human biological material was involved. The study was approved by the Danish Data Protection Agency (1-16-02-126-16).

At inclusion, demographic variables (height and weight) were measured and all participants filled out a Western Ontario and McMaster Universities (WOMAC) questionnaire \[[@CR17]\] consisting of the following items: Pain (5 items), stiffness (2 items) and physical function (17 items). Each score was made using a 100 mm Visual Analogue Scale (0 = no pain/stiffness/physical limitation, 100 = extreme pain/stiffness/physical limitation) with the following ranges: pain = 0-500, stiffness = 0-200, physical function = 0-1700, total score = 0-2400. All participants obtained radiography and MRI of the knee.

Imaging {#Sec5}
-------

One leg weight-bearing radiographs in 30^0^ flexion of both knees were performed in three views: Postero-anterior and lateral views of the tibiofemoral, and axial view of the patellofemoral joint space. The initial lateral radiograph was used as guidance for securing optimal inclination of the lower leg for visualization of the tibiofemoral and patellofemoral joint spaces \[[@CR18]\].

MR examinations were performed using a 1.5 Tesla system (Vision, Siemens, Erlangen, Germany) and a transmit receive four-channel knee coil. The examinations consisted of the following sequences: Sagittal STIR, repetition time (TR) = 5000 ms, echo time (TE) = 29 ms, inversion time = 150 ms, field of view (FOV) = 20 cm, slice thickness (ST) = 4.0 mm, interslice gap (IG) = 0.4 mm, matrix = 266 × 512 pixels, one excitation, and acquisition time (AT) 5.26 min; and sagittal and axial T1-weighted sequences. Gadodiamid (Omniscan, GE Healthcare, Norway) was injected at a peripheral intravenous site (0.1 mmol/kg with a maximum of 10 mmol) using a power injector followed by a saline flush. Sagittal and axial T1 fat suppressed contrast enhanced (T1 FS CE) sequences were performed using the following parameters: TR = 860 ms, TE = 20 ms, FOV = 16 cm, ST = 4.0 mm, IG = 0.8 mm, matrix = 512 × 512 pixels, one excitation, AT 7.23 min per sequence. All sagittal images were obtained perpendicular to the line connecting the dorsal aspect of the medial and lateral femoral condyle. Only the sagittal STIR and the sagittal and axial T1 FS CE images were analyzed in the present study.

Follow-up data acquisition {#Sec6}
--------------------------

Data on TKA procedures were extracted from the Danish National Patient Register, dividing the study population into a TKA and a non-TKA group.

Image analysis {#Sec7}
--------------

Radiographs and MR images were separated and anonymized prior to analysis, and readers were blinded to all study information, including outcome.

The radiographic definition of tibiofemoral (TF) OA was confined to visualization of joint space narrowing in either the medial or the lateral TF joint space. Joint space width of the medial TF articulation less than 3 mm was registered as joint space narrowing \[[@CR19]\]. In addition, medial TF joint space larger than 3 mm but ≥1 mm reduced compared to the medial TF joint space of the other knee was considered joint space narrowing. Lateral TF joint space narrowing was registered when the joint space width was equal to or less than the medial TF joint space. Patellofemoral OA was registered when the medial and/or the lateral joint space width was less than 5 mm \[[@CR20]\].

Radiographic grading was performed by NE and comprised assessment of JSN in the medial and lateral tibiofemoral and patellofemoral articulations according to a modified Ahlbäck grading \[[@CR21], [@CR22]\]. Grade 0 = normal joint spaces, grade 0.5 = \< 50% JSN, grade 1.0 = \> 50%, grade 1.5 = \> 75% and grade 2.0 = 100% JSN; grade 3 = 100% JSN and \< 5 mm bone attrition. Osteophytes (grades 0-3), subchondral sclerosis (0/1) and subchondral cysts (0/1) were also assessed. A radiographic sum score consisting of the scores for JSN, osteophytes, sclerosis and cysts was calculated.

BMLs at the tibiofemoral articulation were analyzed on the sagittal STIR images using a computer assisted segmentation (CAS) method described previously \[[@CR23]\]. In brief, the method was based on pixel segmentation where a signal intensity threshold was calculated in the contralateral femoral condyle and tibial plateau which per definition were unaffected by radiographic OA (see exclusion criteria). The method has proven reliable in detecting even small BMLs compared to manual segmentation \[[@CR23]\]. Because of relatively thick slices and interslice gap only three slices could reliably be measured without partial volume interference. The subchondral bone marrow in the affected femoral condyle and tibial plateau was outlined in all slices, excluding areas with partial volume from surrounding soft tissue. All pixels exceeding the threshold value, defined as the mean signal intensity in the radiographically unaffected compartment plus two standard deviations (SDs), were segmented by the CAS program yielding the BML size of the joint compartment relative to the entire bone marrow volume (relative BML).

All BML segmentations were performed twice by a radiological registrar (FKN) with at least three weeks between repeated measurements. Since inter-observer reliability has been high in a previous study \[[@CR23]\], only intra-observer analyses were performed in the present study.

The relative BML size was ordered into categories using a 1 - 10 point scale (Grade 1 = 0 - 10% BML; grade 2 = \>10 - 20% BML etc.).

Synovitis was assessed and graded according to the methods proposed by Guermazi et al. and Rhodes et al. \[[@CR24], [@CR25]\] on the axial and sagittal T1 FS CE images by NE and AGJ. The thickness of the enhanced synovium was measured at six sites, the medial and lateral parapatellar recesses at the level of the proximal half of the patella; the suprapatellar recess 1 -- 1.5 cm cranial to the patella; at the ventral intercondylar area and dorsal surfaces of the medial and lateral femoral condyles. Grade 0 = no or patchy thin enhancement; grade 1 = even and continuous thickening of the synovial membrane \<2 mm; grade 2 = thickening of the synovial membrane between 2 mm and 4 mm or nodular thickening between 2 mm and 4 mm; grade 3 = even thickening or nodular thickening between 4 mm and 8 mm and grade 4 = \> 8 mm thickening. When the synovial space was separated by fluid, the thicknesses of the two adjacent synovial layers were summed. Sites with one synovial layer, e.g. the femoral condyle surfaces, were graded as follows: grade 1 = \< 1 mm, grade 2 = 1 -- 2 mm, grade 3 = 2 -- 4 mm and grade 4 = \> 4 mm. The synovitis score was summed over all six sites to one total score (maximum score 24). Effusion was measured in mm as the largest sagittal fluid distension of the suprapatellar recess on the midline sagittal T1 FS CE image. Intra- and inter-observer variation was based on 30 randomly chosen examinations.

Synovitis score was ordered into a five point ordinal scale (Grade 1 = 0 - \<5; grade 2 = 5 - \<10 etc.), and effusion score into an eight point ordinal scale (the maximum effusion score was 38) (Grade 1 = 0 - \<5; grade 2 = 5 - \<10 etc.).

Statistical analyses {#Sec8}
--------------------

Data was analyzed using Stata 13.0 (StataCorp, College Station, TX, USA) and Analyse-it software (Analyse-it for Microsoft Excel (version 2.20) Ltd.; 2009).

Baseline characteristics were analyzed descriptively using means and SDs. Associations between baseline factors and any TKA were analyzed using univariate and multivariate logistic regression analyses. Multivariable logistic regression was performed using a single predictor adjusted for other variables (sex, age, body mass index). The extent of any significant association was expressed in odds ratio (OR) with 95% confidence interval (95% CI). Survival analysis comparing the cumulative incidence of TKA over time in relation to JSN, BML, synovitis and effusion was performed using Kaplan-Meier plots \[[@CR24]\] and test for significance was performed using Cox proportional hazard ratio, adjusted for sex, age and BMI.

The association between baseline factors and unilateral vs. bilateral TKA was similarly analyzed using univariate and multivariable logistic regression.

Body mass index (BMI) was divided into four categories: Grade 1 (normal) = \<25 kg/m^2^, Grade 2 (overweight) = 25 - \<30 kg/m^2^, Grade 3 (obese) = 30 - \<35 kg/m^2^ and Grade 4 (very obese) = ≥35 kg/m^2^.

In case of significant associations using logistic regression the scale used for measurement was ordered into categories using a maximum of 10 points.

Intra-observer reliability for BML measurements and intra- and inter-observer reliability for synovitis and effusion grading was assessed by Bland-Altman analyses, using plots, bias and 95% limits of agreement and by intraclass correlation coefficients.

Results {#Sec9}
=======

Baseline characteristics for the 100 participants in the registry study are shown in Table [1](#Tab1){ref-type="table"}. The mean follow-up time was 15.2 years (range 14.2 to 16.4 years). Ninety participants had tibiofemoral OA (80 medial, 10 lateral) and 10 had patellofemoral OA (six medial, four lateral). Baseline demographics of the 17 participants excluded from the MRI analyses due to lack of MRI or patellofemoral OA did not differ from the participants included in the MRI analyses.Table 1Baseline characteristics at inclusion and predictors of knee replacement, univariate and multivariate analysesTotalKnee replacementUnadjustedAdjusted^a^Variable(*n* = 100)Yes (*n* = 66)No (*n* = 34)OR (95% CI)*p* valueOR (95% CI)*p* valueFemale, % (no.)64% (64)68% (45)56% (19)1.0 (0.9 -- 1.0)0.52Age (years), mean (SD)62.0 (10.4)61.3 (10.0)63.4 (10.9)1.0 (0.9 -- 1.0)0.34BMI grade, mean (SD)2.2 (0.9)2.2 (0.9)2.0 (0.9)1.2 (0.8 -- 2.0)0.41WOMAC, mean (SD):*- Pain*184 (89)196 (95)161 (71)1.0 (1.0 -- 1.0)0.07*- Stiffness*81 (45)87(46)67 (40)1.3 (1.01 -- 1.6)^c^0.041.3 (1.01 -- 1.7)^c^0.04*- Function*657 (319)692 (332)588 (281)1.0 (1.0 -- 1.0)0.13*- Total*922 (427)976 (446)817 (366)1.0 (1.0 -- 1.0)0.08Hyalgan %, (no.)48% (48)50% (33)44% (15)1.3 (0.6 -- 2.9)0.58JSN grade, mean (SD)1.7 (1.0)2.0 (0.9)1.0 (0.8)3.6 (2.1 - 6.2)\<0.0015.0 (2.6 - 9.9)\<0.001Radiological sum score, mean (SD)5.0 (2.6)5.8 (2.3)3.4 (2.5)1.5 (1.3 - 1.9)\<0.0011.7 (1.3 - 2.1)\<0.001BML grade, mean (SD)^b^, ^d^2.1 (1.4)2.4 (1.5)1.4 (0.9)2.1 (1.2 -- 3.7)0.0062.3 (1.3 -- 4.0)0.005Synovitis grade, mean (SD)^b^, ^e^2.6 (1.0)2.9 (0.9)2.0 (1.1)2.7 (1.5 -- 4.7)0.0012.8 (1.5 -- 5.2)0.001Effusion grade, mean (SD)^b^, ^f^2.4 (1.5)2.7 (1.6)1.7 (1.1)1.9 (1.2 -- 3.0)0.0051.9 (1.2 -- 3.1)0.006*OR* odds ratio, *CI* confidence interval, *No*. number, *SD* standard deviation, *BMI* body mass index, *WOMAC* Western Ontario and McMaster Universities OA index, *JSN* joint space narrowing, *BML* bone marrow lesion^a^Adjusted for sex, age and BMI; ^b^ Based on 83 participants with MRI scans and tibiofemoral osteoarthritis; ^c^ Logistic regression performed after ordering data into a ten point ordinal scale (Grade 1 = 0 -- 10, grade 2 = 11 -- 20 etc.); ^d^ Ordered into a ten point ordinal scale (Grade 1 = 0 - 10% BML, grade 2 = \>10 - 20% BML etc.); ^e^Ordered into a five point ordinal scale (Grade 1 = 0 - \<5; grade 2 = 5 - \<10 etc.); ^f^ Ordered into an eight point ordinal scale (Grade 1 = 0 - \< 5; grade 2 = 5 - \<10 etc.) (maximum effusion score = 38)

A total of 66 participants had undergone TKA in the knee at follow-up; 37 had also obtained TKA in the other knee. There was no significant association between baseline demographics (sex, age, BMI) or Hyalgan treatment and the risk for TKA at follow-up (Table [1](#Tab1){ref-type="table"}). There was a minor, though significant, association between stiffness item in WOMAC and TKA (adjusted OR 1.3 (95% CI 1.01 -- 1.7)) but not with other WOMAC items.

Significant associations between TKA and JSN (adjusted OR 5.0 (95% CI 2.6 -- 9.9)), radiological sum score (adjusted OR 1.7 (95% CI 1.3 -- 2.1)), BML (adjusted OR 2.3 (95% CI 1.3 -- 4.0)), synovitis (adjusted OR 2.8 (95% CI 1.5 -- 5.2)) and effusion (adjusted OR 1.9 (95% CI 1.2 -- 3.1)) was observed (Table [1](#Tab1){ref-type="table"}). The Kaplan-Meier time to event analysis illustrates the relation between increasing degrees of JSN, BML, synovitis and effusion and the risk of TKA (Fig. [2](#Fig2){ref-type="fig"}). Cox proportional hazard ratio showed a statistically significant hazard ratio for JSN, radiological sum score, BML, synovitis and effusion with the risk for TKA (Table [2](#Tab2){ref-type="table"}).Fig. 2Kaplan-Meier plot showing the cumulative incidence of TKA in relation to different degrees of JSN, BML, synovitis and effusion**.** TKA: total knee arthroplasty; JSN: joint space narrowing; BML: bone marrow lesion Table 2Cox proportional hazard ratiosUnadjustedAdjusted^a^VariableHazard ratio (95% CI)*p* valueHazard ratio (95% CI)*p* valueJSN grade2.2 (1.7 -- 2.9)\<0.0012.2 (1.7 -- 3.0)\<0.001Total radiological score1.3 (1.1 -- 1.4)\<0.0011.3 (1.1 -- 1.4)\<0.001BML grade, ^b^1.5 (1.2 -- 1.7)\<0.0011.5 (1.2 -- 1.8)\<0.001Synovitis grade, ^c^1.5 (1.2 -- 1.9)0.0011.5 (1.2 -- 1.9)0.001Effusion grade, ^d^1.3 (1.1 -- 1.5)0.0021.3 (1.1 -- 1.5)0.001*CI* confidence interval, *JSN* joint space narrowing, *BML* bone marrow lesion^a^Adjusted for sex, age and BMI (body mass index); ^b^ Ordered into a ten point ordinal scale (Grade 1 = 0 - 10% BML, grade 2 = \>10 - 20% BML etc.); ^c^ Ordered into a five point ordinal scale (Grade 1 = 0 - \<5; grade 2 = 5 - \<10 etc.); ^d^ Ordered into an eight point ordinal scale (Grade 1 = 0 - \<5; grade 2 = 5 - \<10 etc.) (maximum effusion score = 38)

The 66 participants with TKA at follow-up were compared in relation to unilateral versus bilateral TKA (Table [3](#Tab3){ref-type="table"}); only BMI was associated with the risk of bilateral vs. unilateral TKA (OR 2.3 (95% CI 1.2 -- 4.3)).Table 3Baseline characteristics and predictors of unilateral versus bilateral knee replacement, univariate and multivariate analysesTotalKnee replacementUnadjustedAdjusted^a^Variable(n = 66)Unilateral (*n* = 29)Bilateral (*n* = 37)OR (95% CI)*p* valueOR (95% CI)*p* valueFemale, % (no.)68% (45)76% (22)62% (23)1.0 (0.9 -- 1.0)0.24Age (years), mean (SD)61.3 (10.0)62.9 (11.0)59.9 (9.0)0.5 (0.2 -- 1.5)0.23BMI, grade, mean (SD)2.2 (0.9)1.9 (0.9)2.5 (0.9)2.3 (1.2 -- 4.3)0.009WOMAC, mean (SD), baseline:*- Pain*196 (95)206 (91)189 (98)1.0 (1.0 -- 1.0)0.481.0 (1.0 -- 1.0)0.42*- Stiffness*87(46)83 (47)91 (44)1.0 (1.0 -- 1.0)0.441.0 (1.0 -- 1.0)0.76*- Function*692 (332)682 (320)701 (340)1.0 (1.0 -- 1.0)0.821.0 (1.0 -- 1.0)0.69*- Total*976 (446)970 (420)981 (465)1.0 (1.0 -- 1.0)0.921.0 (1.0 -- 1.0)0.66JSN grade, mean (SD)2.0 (0.9)1.9 (0.9)2.1 (0.9)1.3 (0.8 -- 2.3)0.302.2 (1.0 -- 4.6)0.05Radiological sum score, mean (SD)5.8 (2.3)5.4 (2.4)6.1 (2.2)1.1 (0.9 -- 1.4)0.261.4 (1.0 -- 1.9)0.05BML grade, mean (SD)^b^, ^c^2.4 (1.6)2.5 (1.7)2.4 (1.5)1.0 (0.7 -- 1.3)0.820.9 (0.6 -- 1.3)0.63Synovitis grade, mean (SD)^b^, ^d^2.9 (0.9)2.8 (1.1)2.9 (0.7)1.2 (0.7 -- 2.1)0.611.1 (0.6 -- 2.1)0.78Effusion grade, mean (SD)^b^, ^e^2.7 (1.6)2.4 (1.7)3.0 (1.5)1.3 (0.9 -- 1.8)0.201.2 (0.8 -- 1.7)0.39*OR* odds ratio, *CI* confidence interval, *No*. number, *SD* standard deviation, *BMI* body mass index, *WOMAC* Western Ontario and McMaster Universities OA index, *JSN* joint space narrowing, *BML* bone marrow lesion^a^Adjusted for sex, age and BMI; ^b^ Based on 56 participants with total knee arthroplasty, accessible MRI scan and tibiofemoral osteoarthritis; ^c^ Ordered into a ten point ordinal scale (Grade 1 = 0 - 10% BML, grade 2 = \>10 - 20% BML etc.); ^d^ Ordered into a five point ordinal scale (Grade 1 = 0 - \<5; grade 2 = 5 - \<10 etc.); ^e^ Ordered into an eight point ordinal scale (Grade 1 = 0 - \<5; grade 2 = 5 - \<10 etc.) (maximum effusion score = 38)

The intra- and inter-observer agreement for all parameters were good (see Additional files [1](#MOESM1){ref-type="media"}, [2](#MOESM2){ref-type="media"}, [3](#MOESM3){ref-type="media"} and [4](#MOESM4){ref-type="media"}). The intraclass correlation coefficients ranged between 0.88 -- 0.99.

Discussion {#Sec10}
==========

Our study showed that radiographic findings, specifically the degree of JSN, and MRI detected BML, synovitis and effusion were highly associated with TKA after 15 years of follow-up. Demographic characteristics such as sex, age or BMI were not correlated with the risk for TKA. There was, however, an association between higher BMI and the risk for bilateral TKA versus unilateral TKA.

The reason for the pronounced association between JSN and TKA could be explained by the surgical criteria for selecting patients with knee OA. According to the Danish national guidelines from 2012, the indications for TKA are primarily based on symptoms and objective findings \[[@CR26]\]. It is, however, likely that the surgeon would generally not operate on a knee without radiographic signs of OA, especially JSN. Thus, a relative contra-indication for TKA is absence of or minimal radiologic changes \[[@CR26]\]. No formalized Danish guidelines existed before 2012 but a comparison of preoperative knee scores from the Danish Registry of Knee Arthroplasty between 2005 and 2009 revealed no differences in disease severity \[[@CR27]\]. Thus, there is no indication that TKA guidelines have changed between 2005 and 2009.

JSN has also previously been shown to be associated with knee OA progression. Oak et al. \[[@CR28]\] found that baseline JSN was significantly correlated with worsening of knee osteoarthritis outcome score (KOOS) for pain, KOOS for symptoms and KOOS for quality of life at 4-year follow-up. In a study by Raynauld et al. \[[@CR9]\], the degree of JSN was significantly associated with subsequent TKA during a follow-up period of six years.

BML, synovitis and effusion were all significantly associated with the risk of TKA and our results are thus in line with previous studies \[[@CR9]--[@CR12], [@CR29]\]. However, while these studies had a relatively short follow-up period (one to six years) we showed that BML, synovitis and effusion were associated with long-term risk of TKA and that increasing degree of changes were associated with faster progression to TKA. MRI are not commonly used in the diagnosis of knee OA and the presence or absence of BML, synovitis or effusion are thus not likely to influence the surgeon's decision to perform a TKA. Instead, BML and synovitis have been found associated with symptoms \[[@CR30]--[@CR32]\] and disease progression \[[@CR33], [@CR34]\], and our results imply that they play a central role in the disease process.

An association between baseline demographics (age, sex) and TKA at follow-up was not found. Although both age and sex are often highlighted as risk factors for knee OA, neither have consistently been associated with disease progression \[[@CR7], [@CR35]\]. Furthermore, we did not find any association between overall WOMAC score and subsequent TKA. The severity of symptoms and progression of knee OA have been associated in some studies \[[@CR10], [@CR36]\], often with a short follow-up. Our study showed that long-term risk of TKA was dependent on the amount of structural changes on radiographs and signs of synovial inflammation or BMLs on MR images.

No significant association was found between baseline BMI and TKA. However, among participants with TKA at follow-up, a higher BMI was associated with an increased risk of bilateral vs. unilateral TKA. Thus, our results suggest that a higher BMI does not increase the risk of TKA in knees with symptomatic OA. However, it seems that an increased BMI predisposes to development of OA in the opposite knee. Other studies have similarly reported that an elevated BMI predisposes to incident but not progression of knee OA \[[@CR2], [@CR5]\]. However, based on the amount of available data, we do not believe that we can draw any firm conclusions on this.

Our study has some limitations. The number of participants was limited compared to other longitudinal studies \[[@CR10]\]. The absence of an axial STIR sequence implied that we were not able to analyze BML in participants with patellofemoral OA using computer-assisted segmentation. The signal intensity threshold was based on measurements in the contralateral joint compartment that was unaffected by radiographic OA. However, MRI changes, including BMLs, are frequently seen in radiographically normal joints and could affect BML calculations. Great care was therefore taken when outlining regions of interest for threshold calculations in the contralateral joint compartment to avoid areas with any signs of pathologic signal disturbances. Our BMI data was limited to baseline data only and we did not know whether BMI changed from baseline to the time of TKA. Furthermore, other pathologies associated with knee OA, e.g. meniscal or ligamentous damage, were not analyzed.

The strengths of our study were the use of a long follow-up period and a high reliability of registry TKA data. Our synovitis and effusion grading was based on contrast enhanced sequences which have been shown to be superior to fluid sensitive sequences.

Conclusions {#Sec11}
===========

In conclusion, we found that radiographic changes associated with knee OA as well as MRI detected BMLs, synovitis and effusion were significantly associated with the risk of TKA in patients with knee OA. Demographic variables including BMI was not associated with TKA in knees already affected by OA. However, an increased BMI was seen in participants who developed knee OA requiring TKA in the opposite knee during follow-up.
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